FDA VRBPAC Meeting: Vaccine Targeting Lineage JN.1 for Fall 2024

I didn’t get a chance to watch the June 5th FDA advisory committee meeting on the new vaccine formulation for Covid-19 for this fall. There is a nice summary on the Minnesota CIDRAP (Center for Infectious Disease Research & Policy).

The committee unanimously upvoted the selection of the JN.1 lineage strain (which includes JN.1, KP.2 etc) for Covid vaccines this fall in the U.S.

As usual, Director Dr. Jerry Weir’s slides (summary slides 22-26) provide excellent background and clear discussion.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

About Me

I’m Jim Amos MD, the creator and author behind this blog. I’m a retired psychiatrist who enjoys playing cribbage, juggling and still loves life-long learning. Watch out; I’m gonna pull your leg! Check out my YouTube site

Contact Form below:

← Back

Thank you for your response. ✨